Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters

Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters

Abstract Background Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and hormonal disorder in women. This study aimed to assess the effect of maternal PCOS on screening of aneuploidy in the first and second-trimesters. Methods This case-control study was conducted in Arash Hos...

Full description

Bibliographic Details
Main Authors:	Narjes Hassan Haivadi, Shahideh Jahanian Sadatmahalleh, Fatemeh Razavinia, Sarang Younesi, Malihe Nasiri, Saeideh Ziaei
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Series:	Journal of Ovarian Research
Subjects:	Polycystic ovary syndrome First-trimester screening test Second-trimester screening test Aneuploidy
Online Access:	https://doi.org/10.1186/s13048-023-01251-w

Similar Items

Influence of Maternal Toxoplasmosis on the Second-Trimester Aneuploidy Screening Test
by: Umit Gorkem, et al.
Published: (2018-08-01)

Screening of Fetal Chromosome Aneuploidies in the First and Second Trimester of 125,170 Iranian Pregnant Women
by: Elham SEYYED-KAVOOSI, et al.
Published: (2015-10-01)

Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks
by: Karadžov-Orlić Nataša, et al.
Published: (2012-01-01)

Value of α-fetoprotein, β-HCG, inhibin A, and UE3 at second trimester for early screening of preeclampsia
by: Farah Farzaneh, et al.
Published: (2019-01-01)

Roc Curve Multivariate Modeling in Detection of Fetal Abnormalities Using Screening Down Syndrome Associated Markers in the First and Second Periods of Pregnancy
by: Hamideh Mohammadnia Kojidi, et al.
Published: (2018-05-01)

First-trimester Doppler ultrasound examination
by: Roxana-Elena Bohiltea, et al.
Published: (2021-12-01)

Umbilical cord diameter at early second trimester: Relation to trisomy 21
by: Sedigheh Hantoushzadeh, et al.
Published: (2019-01-01)

First- and Second-trimester Down Syndrome Screening: Current Strategies and Clinical Guidelines
by: Sheng-Wen Shaw, et al.
Published: (2008-06-01)

FIRST TRIMESTER SCREENING FOR PREECLAMPSIA – A SYSTEMATIC REVIEW
by: Beatrice Mosimann, et al.
Published: (2020-01-01)

The Applicability and Use of Doppler Ultrasonography in The First Trimester
by: Kazım Gezginç, et al.
Published: (2007-08-01)

Efficacy of fetal cardiac axis evaluation in the first trimester as a screening tool for congenital heart defect or aneuploidy
by: Youn-Joon Jung, et al.
Published: (2020-05-01)

Importance of Universal screening for thyroid disorders in first trimester of pregnancy
by: Anupama Dave, et al.
Published: (2014-01-01)

Effect of anti-epileptic drugs on first trimester screening test results
by: Canan Unal, et al.
Published: (2020-11-01)

Does a High-Risk (>1/50) Result for First-Trimester Combined Screening Always Entail Invasive Testing? Which Patients from This Group Might Benefit from cfDNA Testing?
by: Rocío García-Jiménez, et al.
Published: (2022-10-01)

Results of a Five-Year Experience in First Trimester Preeclampsia Screening
by: Stella Capriglione, et al.
Published: (2022-08-01)

Evaluation of the Relationship between Fetal Neck Fold and Diagnosis of Turner Syndrome in the First Trimester of Pregnancy
by: R Armand, et al.
Published: (2020-10-01)

Metabolic parameters in cord blood of neonate of mothers with obese and non-obese PCOS and controls: retrospective cohort study
by: Sanaz Alizadeh, et al.
Published: (2021-03-01)

Navigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications
by: Grzegorz Swiercz, et al.
Published: (2024-03-01)

Concordance-analysis and evaluation of different diagnostic algorithms used in first trimester screening for late-onset preeclampsia
by: Sabrina Schaller, et al.
Published: (2020-04-01)

Impact of Endometrial Preparation on the Maternal and Fetal Cardiovascular Variables of the First Trimester Combined Screening Test
by: Chiara Dallagiovanna, et al.
Published: (2023-10-01)

Current Perspectives of Prenatal Cell-free DNA Screening in Clinical Management of First-Trimester Septated Cystic Hygroma
by: Sherer DM, et al.
Published: (2022-10-01)

Effectiveness of the First Trimester Samrakshan Protocol for the Identification of Pregnant Women at High Risk for Preterm Pre-eclampsia
by: Rijo Mathew Choorakuttil, et al.
Published: (2023-01-01)

Screening for small for gestational age using third-trimester ultrasound markers: protocol for a systematic review and meta-analysis of screening test accuracy
by: Cédric Gasse, et al.
Published: (2018-12-01)

First trimester combined screening for preeclampsia and small for gestational age – a single centre experience and validation of the FMF screening algorithm
by: Beatrice Mosimann, et al.
Published: (2017-08-01)

Cross-trimester repeated measures testing for Down’s syndrome screening: an assessment
by: D Wright, et al.
Published: (2010-07-01)

Low-Dose Aspirin after ASPRE—More Questions Than Answers? Current International Approach after PE Screening in the First Trimester
by: Piotr Tousty, et al.
Published: (2023-05-01)

First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study
by: Cristina Trilla, et al.
Published: (2022-07-01)

Prenatal Risk Calculation (PRC) 3.0: An Extended DoE-Based First-Trimester Screening Algorithm Allowing For Early Blood Sampling
by: E. Merz, et al.
Published: (2016-02-01)

“Hypothyroidism screening during first trimester of pregnancy”
by: María Castillo Lara, et al.
Published: (2017-12-01)

Patient-friendly integrated first trimester screening by NIPT and fetal anomaly scan
by: Malgorzata Ilona Srebniak, et al.
Published: (2021-01-01)

Rare chromosomal abnormalities: Can they be identified using conventional first trimester combined screening methods?
by: Daniel Kane, et al.
Published: (2021-04-01)

Screening for Preeclampsia and Fetal Growth Restriction in the First Trimester in Women without Chronic Hypertension
by: Piotr Tousty, et al.
Published: (2023-08-01)

Correlation of Pregnancy Associated Plasma Protein A and Zinc with Calculated Risk Ratio of Dual Test
by: Indranil Ghoshal, et al.
Published: (2017-09-01)

Indigenization of the median of markers for Down syndrome screening based on statistical analysis of medical big data
by: Zhu-Ming Hu, et al.
Published: (2020-07-01)

Mean arterial blood pressure: potential predictive tool for preeclampsia in a cohort of healthy nulliparous pregnant women
by: Jussara Mayrink, et al.
Published: (2019-12-01)

The Relationship of the First/Third Trimester Hematocrit level with the Birth Weight and Preeclampsia
by: Massomeh Goudarzi, et al.
Published: (2008-11-01)

Clinical significance of soft markers in second trimester ultrasonography for pregnant Korean women: a multicenter study and literature review
by: Hyun Sun Ko, et al.
Published: (2022-03-01)

The impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study
by: Ching Hua Hsiao, et al.
Published: (2022-01-01)

Second-trimester Maternal Serum Quadruple Test for Down Syndrome Screening: A Taiwanese Population-based Study
by: S.W. Steven Shaw, et al.
Published: (2010-03-01)

Trimester-specific reference interval for thyroid hormones during pregnancy at a Tertiary Care Hospital in Haryana, India
by: Rajesh Rajput, et al.
Published: (2016-01-01)